Hans Heiken
Hannover, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Switching to a NRTI-free 2 drug regimen (2DR) -a sub-analysis of the 48 weeks DUALIS study on metabolic and renal changes.
Journal: HIV research & clinical practice
Published: March 02, 2022
Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance.
Journal: AIDS research and therapy
Published: May 08, 2021
Health-related quality-of-life in people living with HIV after switching to dual therapy with ritonavir-boosted darunavir + dolutegravir: a DUALIS sub-study.
Journal: AIDS care
Published: April 26, 2021
High prevalence of comorbidities and use of concomitant medication in treated people living with HIV in Germany - results of the BESIDE study.
Journal: International journal of STD & AIDS
Published: December 16, 2020
Improved Prognosis of Infection With Mycobacterium Genavense in Immune-Compromized HIV Patients After Introduction of Combined Antiretroviral Therapy.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: September 18, 2020
Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS Study.
Journal: Open forum infectious diseases
Published: June 08, 2020
Antiretroviral treatment for HIV: is it time for 2 drug regimens?
Journal: MMW Fortschritte der Medizin
Published: June 09, 2019
Chronic hepatitis C patients prior to broad access to interferon-free treatments in Germany.
Journal: Zeitschrift fur Gastroenterologie
Published: August 17, 2016
Analysis of contemporary HIV/AIDS health care costs in Germany: Driving factors and distribution across antiretroviral therapy lines.
Journal: Medicine
Published: July 02, 2016
The choice between a ritonavir-boosted protease inhibitor- and a non-nucleoside reverse transcriptase inhibitor-based regimen for initiation of antiretroviral treatment - results from an observational study in Germany.
Journal: Journal of pharmaceutical policy and practice
Published: October 12, 2015
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 08, 2015
Last Updated: 09/26/2026